{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:47:54Z","timestamp":1771037274939,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1124\/jpet.115.229641","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T20:52:39Z","timestamp":1455223959000},"page":"66-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection"],"prefix":"10.1016","volume":"357","author":[{"given":"Gopinath","family":"Kasetty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Papareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi K.V.","family":"Bhongir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Egesten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.115.229641_bib1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.115.229641_bib2","doi-asserted-by":"crossref","first-page":"e74640","DOI":"10.1371\/journal.pone.0074640","article-title":"Roflumilast inhibits lipopolysaccharide-induced tumor necrosis factor-\u03b1 and chemokine production by human lung parenchyma","volume":"8","author":"Buenestado","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.115.229641_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.115.229641_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(09)61255-1","article-title":"Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials","volume":"374","author":"Calverley","year":"2009","journal-title":"Lancet"},{"key":"10.1124\/jpet.115.229641_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(09)61252-6","article-title":"Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials","volume":"374","author":"Fabbri","year":"2009","journal-title":"Lancet"},{"key":"10.1124\/jpet.115.229641_bib6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/thx.2006.075937","article-title":"Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD","volume":"62","author":"Grootendorst","year":"2007","journal-title":"Thorax"},{"key":"10.1124\/jpet.115.229641_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3565(24)29537-9","article-title":"Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro","volume":"297","author":"Hatzelmann","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.229641_bib8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/01.RES.0000261934.56938.38","article-title":"cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling","volume":"100","author":"Houslay","year":"2007","journal-title":"Circ Res"},{"key":"10.1124\/jpet.115.229641_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2334-14-163","article-title":"Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population\u2014a population based cohort study","volume":"14","author":"Inghammar","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1124\/jpet.115.229641_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bjp.0705927","article-title":"Role of PDE4 in superoxide anion generation through p44\/42MAPK regulation: a cAMP and a PKA-independent mechanism","volume":"143","author":"Jacob","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.229641_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pupt.2004.10.001","article-title":"The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro","volume":"18","author":"Jones","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/jpet.115.229641_bib12","doi-asserted-by":"crossref","first-page":"e0121725","DOI":"10.1371\/journal.pone.0121725","article-title":"The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation","volume":"10","author":"Konrad","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.115.229641_bib13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1124\/jpet.105.092056","article-title":"Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation","volume":"315","author":"Kwak","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.229641_bib14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/bjp.2008.180","article-title":"The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke","volume":"154","author":"Le Qu\u00e9ment","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.229641_bib15","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1164\/rccm.200411-1549OC","article-title":"Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke","volume":"172","author":"Martorana","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.115.229641_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1124\/jpet.106.105080","article-title":"Phosphodiesterase type 4 inhibitors cause proinflammatory effects in vivo","volume":"319","author":"McCluskie","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.229641_bib17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.200709-1413OC","article-title":"Pseudomonas aeruginosa in chronic obstructive pulmonary disease","volume":"177","author":"Murphy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.115.229641_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-3-642-17969-3_17","article-title":"Phosphodiesterase inhibitors in the treatment of inflammatory diseases","volume":"204","author":"Page","year":"2011","journal-title":"Handbook Exp Pharmacol"},{"key":"10.1124\/jpet.115.229641_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.coph.2012.02.016","article-title":"Selective PDE inhibitors as novel treatments for respiratory diseases","volume":"12","author":"Page","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/jpet.115.229641_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000347132","article-title":"Damage-associated molecular patterns control neutrophil recruitment","volume":"5","author":"Pittman","year":"2013","journal-title":"J Innate Immun"},{"key":"10.1124\/jpet.115.229641_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1465-9921-12-18","article-title":"Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD","volume":"12","author":"Rennard","year":"2011","journal-title":"Respir Res"},{"key":"10.1124\/jpet.115.229641_bib22","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.115.229641_bib23","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax"},{"key":"10.1124\/jpet.115.229641_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI0215277","article-title":"Cytokines in innate host defense in the lung","volume":"109","author":"Strieter","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.115.229641_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1515\/acph-2015-0016","article-title":"The role of phosphodiesterase 4B in IL-8\/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor","volume":"65","author":"Suzuki","year":"2015","journal-title":"Acta Pharm"},{"key":"10.1124\/jpet.115.229641_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1254\/jphs.13103FP","article-title":"Evaluation of the therapeutic index of a novel phosphodiesterase 4B-selective inhibitor over phosphodiesterase 4D in mice","volume":"123","author":"Suzuki","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.115.229641_bib27","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.115.229641_bib28","first-page":"CD010257","article-title":"Antibiotics for exacerbations of chronic obstructive pulmonary disease","volume":"12","author":"Vollenweider","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/jpet.115.229641_bib29","doi-asserted-by":"crossref","unstructured":"Walters JA, Gibson PG, Wood-Baker R, Hannay M, Walters EH (2009) Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (1):CD001288.","DOI":"10.1002\/14651858.CD001288.pub3"},{"key":"10.1124\/jpet.115.229641_bib30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1465-9921-11-126","article-title":"Pharmacological characterisation of anti-inflammatory compounds in acute and chronic mouse models of cigarette smoke-induced inflammation","volume":"11","author":"Wan","year":"2010","journal-title":"Respir Res"},{"key":"10.1124\/jpet.115.229641_bib31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1164\/rccm.200210-1179OC","article-title":"Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease","volume":"167","author":"Wilkinson","year":"2003","journal-title":"Am J Respir Crit Care Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652419283X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652419283X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.115.229641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:43:44Z","timestamp":1739994224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652419283X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S002235652419283X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.115.229641","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.115.229641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}